A B S T R A C T Clearance experiments were performed in female mongrel dogs, either intact or thyro-parathyroidectomized (T-PTX), under pentobarbital anesthesia, to examine the unusual hypocalciuric property of thiazide diuretics. The relationship between calcium clearance (Cca) and sodium clearance (CNa) was determined in normal dogs, CCa = 0.79 CNa; constant infusion of chlorothiazide (CTZ) to provide drug concentrations in plasma of approximately 40 Ag/ml modified this relationship; CCa = 0.30 CNa (P < 0.001). The magnitude of the dissociating effect of CTZ on the urinary Ca/Na relationship was found to be most highly correlated with urinary drug concentration. Infusion of CTZ (1 mg/ min) into one renal artery caused a unilateral decrease (25%) in Cca/GFR while producing a unilateral increase (80%) in CNa/GFR. The same dose of CTZ in T-PTX dogs produced an increase in CNa/GFR without causing a change in Cca/GFR. The defective response in T-PTX dogs could be ascribed to poor tubular secretion of the drug; when urinary drug concentrations were elevated in T-PTX dogs to the levels found in intact dogs (by infusing more drug), Cca/GFR fell to an equivalent extent. T-PTX dogs showed substantially lower renal extraction of CTZ (42%) than intact dogs (57%); PTH administration to T-PTX dogs increased extraction toward normal (49%). The defective secretion of CTZ could not be attributed to either a decreased tubular maximum or a decreased renal blood flow. Dr. Costanzo's present address is Department of Physiology, Cornell University Medical College, New York.
INTRODUCTION
Received for publication 13 March 1974 and in revised form 10 Mai, 1974. on initial administration they do not enhance calcium excretion in proportion to sodium excretion (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . This phenomenon is seen in most subjects, including those with hypoparathyroidism (11) (12) (13) . Second, during sustained administration, thiazides cause a persistent reduction in calcium excretion (4, 5, 11-13, 15, 16) . The latter phenomenon has been observed in most subjects, but not those with hypoparathyroidism (12, 13) .
Several hypotheses have been advanced to explain the effects of thiazides on calcium excretion and the impaired response in hypoparathyroid patients. Among the factors considered in these hypotheses are: the role of extracellular volume depletion (16, 17) , direct stimulation of the parathyroid glands by the drugs (18), enhancement or potentiation of the renal calcium-retaining action of parathyroid hormone (PTH)1 (12, 13) , and direct actions on the renal tubules (19) . There is direct or probable evidence against some of these hypotheses (see below). Moreover, no one of the hypotheses advanced thus far can be itself explain all of the phenomena described above.
This paper summarizes the results of a study examining the acute hypocalciuric action of chlorothiazide (CTZ) in intact and thyro-parathyroidectomized (T-PTX) dogs. The results establish that the thiazides affect calcium excretion in large part by a direct action on the kidney. In these experiments, hypoparathyroidism modified this action of thiazides by influencing pharmacokinetics, not by making the kidney unresponsive to the drug. The results suggest that the dual action of thiazides (natriuretic and hypocalciuric) may be manifestations of a single effect. Finally, the results help explain why the acute administration of thiazides may cause variable effects on the magnitude of calcium clearance. 1 Abbreviations used in this paper: ADH, antidiuretic hormone; Art, concentration in arterial plasma; C, clearance; c-AMP, cyclic AMP; CTZ, chlorothiazide; GFR, glomerular filtration rate; P, concentration in plasma; PTH, parathyroid hormone; T, secretory rate; Tm, tubular maximum; T-PTX, thyro-parathyroidectomized; U, concentration in urine; V, urinary flow rate; Ven, concentration in renal venous plasma.
METHODS
70 clearance experiments were performed in female mongrel dogs anesthetized with sodium pentobarbital, 30 mg/kg, i.v.
They were deprived of food but not water for 18 h before experiments. Enough inulin was infused to provide plasma concentrations of approximately 40 mg/100 ml. Blood samples were taken from the femoral artery at midpoints of clearance periods. Urine collections were usually made through ureteral cannulas placed near the bladder via a lower abdominal incision. Indwelling bladder catheters were used in those dogs subject to repeated experiments; bladders were washed out with 10 ml of 5%o mannitol before the start of a set of clearance periods and at the end of each clearance period. In experiments involving intra-arterial infusions, the left renal artery was exposed via a flank incision. A curved 23-gauge needle was inserted into the artery as close as possible to the aorta and proximal to any bifurcations. Dogs with multiple renal arteries were not used. The needles were kept patent by the infusion of 0.9% NaCl at 0.68-0.76 ml/min. During appropriate clearance periods, drugs were added to the intra-arterial infusion. For collection of renal venous blood, the left renal vein was approached via a flank incision and a curved 23-gauge needle was placed in the renal vein between the kidney and the ovarian vein. The needle was kept in position (pointing toward the kidney) by applying tension in the appropriate direction. The needle and its connecting tubing was filled with heparinized saline when not in use.
Some experiments were performed in T-PTX dogs. These animals were subjected to the operation 48 h before experiments (20) . On the day of operation, after recovery from anesthesia, the animals were given 25 g of calcium lactate mixed with canned dog food. On the subsequent day, the dose of calcium lactate was repeated and each animal received 30 mg of dessicated thyroid orally.
Effect of CTZ on Na-Ca relationship. Control experiments (five dogs, 15-29 kg) began with the i.v. infusion of 0.9% NaCl at 5 ml/min for 40 min; at the end of this time a series of 13 10-min clearance periods were started. During these periods, urine flow was varied over a wide range by adding mannitol (5-15%) to (16-21 kg) were loaded with 500 ml of 5% mannitol in 0.9%o NaCl given at the rate of 21 ml/min. An infusion of similar composition was continued at 8.6 ml/min for the remainder of the experiment. 40 min after completion of the loading infusion, two 10-min control clearance periods were taken. CTZ was added to the infusions in amounts resulting in delivery of 1.5-7 mg/min in different dogs.
This procedure resulted in slowly rising concentrations of CTZ in plasma and urine over the ensuing six clearance periods.
Additional experiments of generally similar design were performed in three dogs (17-20 kg) . In these experiments, urine flows were lower than in the preceding set because the initial load of mannitol-saline was either eliminated or decreased.
Renal arterial infusions of drugs. These experiments were patterned after those of Lavender and Pullman (21) . The experimental protocol and weights of the dogs will be apparent from Tables I and II. Tubular maximum (Tm) CTZ experimients. Four dogs (17-20 kg) were studied before and after thyro-parathyroidectomy. The dogs lost an average of 1.0 kg between the two experiments. An initial load of 20 mg of CTZ and a sustaining infusion (5 ml/min) of 2% mannitol in 0.9%o NaCl, containing CTZ to deliver 1.25 mg/min, were given i.v. 40 min after beginning the experiments, two 10-min periods were taken. Three additional levels of CTZ in the plasma were achieved by administering loads of 60 mg, 320 mg, and 400 mg of CTZ and increasing the CTZ in the infusions to deliver 5, 25, and 50 mg/min, respectively. 20 min were allowed to elapse after the beginning of each new infusion; two 10-min clearance periods were then taken. The secretory rate (T)CTZ was calculated as the difference between UcTVV and filtered CTZ [glomerular filtration rate (GFR) X CTZ concentration in an ultrafiltrate of plasma].
Renal blood flow experiments. 10 normal dogs (14-24 kg) and 5 T-PTX dogs (16-19 kg) were used. Urine Incas collected separately from each kidney. A solution of 0.9% NaCl containing CTZ (5 mg/min) was infused at 5 ml/ min throughout the experiment. After a 2-h equilibrium period, three 10-min control periods were taken. At the midpoint of each period, arterial and renal venous blood were sampled simultaneously. After the control periods in T-PTX dogs, the animals were treated with either parathyroid extract (Eli Lilly & Co., Indiananolis. Ind.) or a biologically active .svnthetic frairment of PTH (Beckman Instruments, Inc., Fullerton, Calif.). 100 U was given as a loading dose, and the hormone was added to the infusion to deliver 3 U/min. 5 min after the loading dose of hormone, a series of three 10-min collections was started. Since the results with the extract and the synthetic fragrment were essentially the same. the data were pooled. Renil olasma flow was calculated on the basis of the CTZ determinations according to the Wolf equation (22) Clearances and clearance ratios in the figures and tables are calculated in terms of total plasma calcium. Sufficient data are provided for the reader to convert these to fractional excretion if desired. ments yielded data that do not conform to the others in two of the scattergrams, but fit reasonably well in the mass plot with UCTZ on the abscissa. There are already results in the literature that suggest that the natriuretic (29) 
RESULTS
Effect of CTZ infusion on the relationship between calciumt and sodium clearance ratios in intact dogs. Fig.  1 confirms the linear relationship between the clearance ratios of calcium and sodium in normal dogs (28) . Also shown are the results from dogs receiving intravenous CTZ. Under the influence of the drug, the clearance ratios for calcium and sodium remained linearly related but at any level of sodium excretion, calcium reabsorption was enhanced, compared to controls. The slopes of the regression lines are significantly different; P < 0.001; the intercept ( Fig. 1 ) is not significantly different from zero. Mean values for GFR, concentration in plasma (P)ca and percent of Pca ultrafilterable in the control and experimental groups were not significantly different; they were 56.9±3.4 and 53.1±+3.0 ml/min; 2.51±+0.03 and 2.65±0.04 mM; and 68.3±+1.9 and 67.2±1.3%, respectively. Not given in the figure are the equations based on the clearance ratio for ultrafilterable calcium. They are y = 1.17 x + 0.008 and y = 0.46 x -0.003 for control and CTZ groups, respectively; the slopes are significantly different (P < 0.001). Dose-response relationship. A series of 10 clearance experiments was performed in dogs undergoing osmotic diuresis in which the effects of increasing levels of CTZ were monitored. The fall in the ratio Cca/CCa (expressed as a percent of the predrug ratio), is plotted as a function of PCTZ, UCTZV, and UCTZ in Fig. 2 , closed symbols. In each of the scattergrams there seems to be a positive correlation between the drug parameter and the magnitude of effect. Also included in this figure are 18 data points from three dogs in which there was minimal background osmotic diuresis, i.e. urine flows were generally lower than in the other ten experiments. These experi- lated to drug concentration in urine (tubular fluid) rather than total quantity of drug in urine.
In the experiments described in the preceding section, we encountered urinary concentrations of CTZ from 400 to 3,000 Ag/ml. Over this range of concentrations, there was no consistent change in Cca/CNa. Consequently, we assume that the lower line in Fig. 1 describes the maximal or near-maximal effect of CTZ.
Renal arterial infusions of CTZ or furosemide. Table  I gives the details of an experiment in which CTZ, 1 mg/min, was infused into one renal artery of a normal dog. During the control periods renal function was approximately the same in both kidneys. During the infusion of CTZ into the left renal artery, there was essentially no change in GFR, but there was a considerable increase in CNa/GFR on the left side, a smaller increase on the right, a 25% decline of Cca/GFR on the left side, and no change on the right. As a consequence of these changes, the ratio Cca/CNa fell from 0.66 to 0.23 on the infused side and less on the control side. There seemed to be a small unilateral effect on Cpo4/GFR in this experiment, but this was not a consistent finding. This experiment and four others are summarized in Table II (group 2). The grouped data are consistent with the foregoing description of the single experiment.
Cyclic AMP (c-AMP) excretion was evaluated in this same group of dogs. Before drug infusions, c-AMP excretion was 505±99 and 477±36 pmol/min from the experimental and control kidneys, respectively. During drug infusion, c-ANIP excretion was lower from both kidneys; the changes were -117±111 and -76±62 pmol/nmin from the experimental and control kidneys, respectively. These changes were not statistically significant. In view of the negative results, determinations of c-AMP excretion were omitted from the studies described subsequently.
The foregoing results on electrolyte clearances are to be compared with those from similar experiments with furosemide (Table II, Fig. 3 .
The mean value for CCa/CNa in T-PTX dogs (n = 10) was 0.96±0.04, significantly higher than the mean ratio, 0.82±0.04, in intact dogs (n =15), P <0.01.
The values for plasma electrolytes in the five groups of dogs are listed in Table III infusions result in a significant change in any of the parameters measured. There were significant differences between intact and T-PTX dogs in Pca and percent of Ca ultrafilterable. The means of pooled data for plasma calcium were 2.76±0.05 mM for intact dogs and 2.07± 0.06 mM for T-PTX dogs, P < 0.001. The means for percent of Ca ultrafilterable were 72.9±0.9% for intact dogs and 60.2+1.2% for T-PTX dogs, P < 0.001. The values for PPo4, 1.39±0.07 mM (intact) and 1.53± 0.12 mM (T-PTX), were not significantly different.
TmnCTZ. The Tm for chlorothiazide was determined in four normal dogs. 8 days later a thyro-parathyroidectomiy was performed and the Tm experiments were repeated 48 h after surgery. Fig. 4 displays the results from one dog according to Shannon's convention (31) . The dog weighed 17.0 kg before and 16.0 kg after T-PTX.
There was no significant difference in T/GFR at the two highest plasma concentrations in each experiment, and thus it is assumed that the mean of these values gives the Tm/GFR. In the control experiment the mean value Table I for GFR was 44.2 ml/min; after T-PTX the mean value was 44.4 ml/min. The value for Tm/GFR decreased only slightly after T-PTX. These findings were confirmed in the other dogs. The mean value for Tm/GFR before T-PTX was 312+15 jtg/ml; after surgery the mean was 278±19 Ag/ml. The mean value for GFR was 44.2±2.9 ml/min before surgery and 48.2±3.9 after. The foregoing differences were not statistically significant.
There was, however, a significant difference in the clearance ratios for CTZ at plasma concentrations well below those necessary for saturation, i.e., less than 50 gg/ ml. In the intact state, CCTz/GFR was 2.38±0.17 and after T-PTX, 1 (28) in dogs has been repeatedly confirmed (32) (33) (34) (35) (36) .
There is no precise agreement on the slope of the line relating the two fractional excretions (FE) ; the equations vary from fractional excretion FEca = 0.83 FENa + A to FEca = 1.21 FENa + A; A is the intercept, which is also not exactly the same in all studies. The present results fall within the range described in the literature. The foregoing relationship is known to be disturbed by several interventions, including mineralocorticoid excess or deficiency (37) , acidosis (38) parathyroid hormone administration or deficiency (39) (40) (41) (42) , and the administration of thiazide diuretics, but not most other diuretics (43) (44) (45) (46) (47) .
The initial administration of a thiazide may result in an increase (5, 7, 10), a decrease (3, 6) , or no change (1, 2, 9, (11) (12) (13) in fractional calcium excretion. The variable response can, in large part, be explained by the data in Fig. 1 . Points A and B depict the mean results (left kidneys) from group 2, Table II before and after CTZ, respectively. It is apparent that the change in Cca/GFR can be very nearly predicted from the initial starting point, the slopes of the lines, and the increment in CNa/GFR. Points C and D are the means of clearance data before and after CTZ from the study of Edwards, Baer, Sutton, and Dirks (14), using saline-expanded dogs. Their results fit reasonably well with this scheme. Note that the increments in CNa/GFR were approximately the same in our experiments (A and B) and in those of Edwards et al. (C and D) . The difference in response of Cca/GFR is attributable to the different starting points on the control line. We also infer from Fig. 1 that differences in the magnitude of natriuretic response to CTZ from the same starting point will also condition the direction and magnitude of acute changes in Cca/GFR. It seems probable that the failure to observe an absolute fall in calcium excretion in human subjects (12, 13) on the first day of thiazide administration is attributable to these factors. These human studies were conducted in a setting of relatively low initial CNa/ GFR and on the first day of diuretic administration there was a brisk natriuresis.
The present results indicate that volume depletion is not a necessary condition for demonstrating a hypocalciuric response to a thiazide. First, on renal arterial drug infusion there was unilateral fall in calcium clear-ance. Volume depletion would be expected to influence both kidneys equally. Second, the hypocalciuric effect was observed in the first clearance period after initiating CTZ infusion (Table I) . Over the 15 min intervening between the start of drug infusion and the end of the first period, the difference between urine flow (both kidneys) and infusion rate totaled only 1.5 ml in the experiment illustrated; i.e., there was no substantial volume depletion. A similar absolute decline in Cca had previously been reported by Walser When given into one renal artery, CTZ produced a largely ipsilateral hypocalciuric effect (Table II) , indicating that the drug acts directly on the kidnev. This evidence for a direct renal action is consistent with a suggestion made by Walser (19) . He postulated that thiazides inhibit sodium reabsorption at a distal site where calcium and sodium reabsorption are not coupled and may in fact be negatively correlated.
Brickman, Massry, and Coburn (12) , in discussing the possibility that thiazides potentiate the action of PTH on the nephron, suggested that this potentiation might be the result of thiazides inhibiting phosphodiesterase (50) , thereby enhancing the hormone-induced elevated level of c-AMP. A variant of this hypothesis is tenable for the acute effect of thiazides, if one grants the possibility that inhibition of the enzyme per se is sufficient to raise c-AMIP levels in the absence of PTH. The failure to find elevated c-AMP excretion after thiazide administration does not eliminate the hypothesis. The action of thiazides on calcium excretion (14) , like the actions of PTH on calcium excretion (39, 42, 51) and antidiuretic hormone (ADH) on urinary osmolality (52) , occurs in the distal nephron. With ADH, which presumably acts via a c-AMP mechanism, it has not been possible to demonstrate enhanced excretion of c-AMP (52 In the present study, the probable cause for the defective response to CTZ in dogs 48 h after thYro-parathyroidectomy is reduced secretion of the drug. It is known that the natriuretic action of thiazides in dogs (29) and the hypocalciuric action in man (30) are reduced by the administration of probenecid. The latter drug inhibits the secretion of thiazides (53) . Such results are consistent with our conclusion that the concentration of thiazide in tubular fluid determines the magnitude of effect. We have not yet been successful in elucidating the nature of the defect in drug secretion caused by thyro-parathyroidectomy. Our experiments rule out the possibility that the Tm for secretion is seriously diminished or that diminished renal blood flow is responsible for decreased delivery of drug to the kidney. It may be that our T-PTX dogs had an alteration in the transport mechanism, such that its affinity for the drug was diminished when drug concentration was less than that required for saturation. It is also conceivable that the distribution of blood flow in these dogs was such that those nephrons or portions of nephrons secreting CTZ were relatively poorly perfused.
The present results do not seem relevant to the observation that thiazides administered chronically fail to elicit hypocalciuria in hypoparathyroid humans (12, 13) . It is emphasized that in the experiments with unilateral drug infusion, the remarkable dependence of hypocalciuria on urinary drug excretion was entirely fortuitous. The experimental conditions and the dose of CTZ (1 mg/min) were such that urinary drug concentrations were critical (Fig. 3) . It is unlikely that a small difference in CTZ excretion of the magnitude encountered here can explain the defective response of humans with hypoparathyroidism. For example, in a study by Brickman et al. (12) , the saime-absolute dose of hydrochlorothiazide was administered to both normal and hypoparathyroid subjects. However, the body weights in the two groups were different, so that the average dose on a body-weight basis was 30% higher in the hypoparathyroid group. Theoretically this should have compensated for any defect in drug excretion of the magnitude observed in our dogs. A similar conclusion can be reached from a study by Parfitt (13) . Moreover, in a preliminary study, we have not observed defective excretion of CTZ in humans with chronic stable hypoparaThe Hypocalciuric Action of Chlorothiazide thyroidism, as compared to normal subjects when the Irug was administered intravenously. Such considerations do not rule out other pharmacokinetic bases (e.g. poor intestinal absorption) for the defective response.
